Suppr超能文献

由于改良植入方案,经导管主动脉瓣置换术采用Lotus装置植入后永久性起搏器植入率较低。

Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.

作者信息

Krackhardt Florian, Kherad Behrouz, Krisper Maximilian, Pieske Burkert, Laule Michael, Tschöpe Carsten

机构信息

Department of Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany, Germany.

出版信息

Cardiol J. 2017;24(3):250-258. doi: 10.5603/CJ.a2017.0024. Epub 2017 Mar 1.

Abstract

BACKGROUND

Conduction disturbances requiring permanent pacemaker implantation following transcatheter aortic valve replacement (TAVR) are a common problem. Pacemaker implantation rates after TAVR appear to be higher compared to conventional aortic valve replacement. The aim of this study was to analyze whether a high annulus implantation conveys the benefit of a decreased rate of permanent pacemaker implantation while being safe and successful according to Valve Academic Research Consortium 2 (VARC2)-criteria.

METHODS

A total of 23 patients with symptomatic severe aortic valve stenosis, an aortic annulus of 19-27 mm and at high risk for surgery were treated with the Lotus valve. In all patients the valve was implanted in a high annulus position via femoral access. The primary device performance endpoint was VARC2-defined device success after 30 days and the primary safety endpoint was the need for permanent pacemaker implantation.

RESULTS

The mean age was 73.23 ± 7.65 years, 46% were female, 38% were New York Heart Association class III/IV at baseline. Thirty-day follow-up data were available for all patients. The VARC2-defined device success rate after 30 days was 22/23 (96%). 2/21 (10%) patients required a newly implanted pacemaker due to 3rd degree atrioventricular block. 25% of the patients developed a new left bundle branch block after valvuloplasty or device implantation. 21 of the 23 patients (96%) had no other signs of conduction disturbances after 30 days.

CONCLUSIONS

The approach of the modified implantation technique of Lotus TAVR device was safe and effective. The incidence of need for a permanent pacemaker following TAVR could be significantly reduced due to adopted implantation protocol.

摘要

背景

经导管主动脉瓣置换术(TAVR)后需要植入永久性起搏器的传导障碍是一个常见问题。与传统主动脉瓣置换术相比,TAVR后的起搏器植入率似乎更高。本研究的目的是分析高位瓣环植入是否能在符合瓣膜学术研究联盟2(VARC2)标准的情况下,带来降低永久性起搏器植入率的益处,同时确保安全且成功。

方法

共有23例有症状的严重主动脉瓣狭窄、主动脉瓣环直径为19 - 27mm且手术风险高的患者接受了Lotus瓣膜治疗。所有患者均通过股动脉途径将瓣膜植入高位瓣环位置。主要器械性能终点是30天后VARC2定义的器械成功,主要安全终点是是否需要植入永久性起搏器。

结果

平均年龄为73.23±7.65岁,46%为女性,38%在基线时为纽约心脏协会III/IV级。所有患者均有30天的随访数据。30天后VARC2定义的器械成功率为22/23(96%)。2/21(10%)的患者因三度房室传导阻滞需要新植入起搏器。25%的患者在瓣膜成形术或器械植入后出现新的左束支传导阻滞。23例患者中有21例(96%)在30天后没有其他传导障碍的迹象。

结论

Lotus TAVR器械改良植入技术的方法是安全有效的。由于采用了植入方案,TAVR后需要永久性起搏器的发生率可显著降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验